The effects of the vascular disrupting agents combretastatin A-4 disodium phosphate, 5,6-dimethylxanthenone-4-acetic acid and ZD6126 in a murine tumour: A comparative assessment using MRI and MRS

Author： Breidahl Tomas   Nielsen Flemming   Stødkilde-Jørgensen Hans   Maxwell Ross   Horsman Michael  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.45, Iss.3, 2006-04, pp. : 306-316

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparative effects of combretastatin A-4 disodium phosphate and 5,6-dimethylxanthenone-4-acetic acid on blood perfusion in a murine tumour and normal tissues

By Murata R.   Overgaard J.   Horsman M. R.  

International Journal of Radiation Biology, Vol. 77, Iss. 2, 2001-02 ,pp. : 195-204

Informa Healthcare

Access to resources Recommend Favorite

The effect of combretastatin A4 disodium phosphate and 5,6-dimethylxanthenone-4-acetic acid on water diffusion and blood perfusion in tumours

By Chen Gang   Horsman Michael   Pedersen Michael   Pang Qi   Stødkilde-jørgensen Hans  

Acta Oncologica, Vol. 47, Iss. 6, 2008-08 ,pp. : 1071-1076

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics of 5,6-dimethylxanthenone-4-acetic acid (AS1404), a novel vascular disrupting agent, in phase I clinical trial

By Jameson M.   Baguley B.   Kestell P.   Zhao L.   Paxton J.   Thompson P.   Waller S.  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 5, 2007-04 ,pp. : 681-687

Springer Publishing Company

Access to resources Recommend Favorite

Potentiation of the anti-tumour effect of hyperthermia by combining with the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid

By Murata R.   Overgaard J.   Horsman M. R.  

International Journal of Hyperthermia, Vol. 17, Iss. 6, 2001-11 ,pp. : 508-519

Informa Healthcare

Access to resources Recommend Favorite

Tumour-specific enhancement of thermoradiotherapy at mild temperatures by the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid

By Murata R.   Horsman M. R.  

International Journal of Hyperthermia, Vol. 20, Iss. 4, 2004-06 ,pp. : 393-404

Informa Healthcare

Access to resources Recommend Favorite